{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:48:22Z","timestamp":1790966902851,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T00:00:00Z","timestamp":1314662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10096-011-1385-9","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T09:40:11Z","timestamp":1314610811000},"page":"859-865","source":"Crossref","is-referenced-by-count":25,"title":["Streptococcus pyogenes bacteraemia, emm types and superantigen profiles"],"prefix":"10.1007","volume":"31","author":[{"given":"S.","family":"Rantala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"V\u00e4h\u00e4kuopus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Siljander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vuento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,30]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","volume":"14","author":"DL Stevens","year":"1992","unstructured":"Stevens DL (1992) Invasive group A Streptococcus infections. Clin Infect Dis 14:2\u201311","journal-title":"Clin Infect Dis"},{"key":"1385_CR2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3201\/eid0908.020745","volume":"9","author":"SH Factor","year":"2003","unstructured":"Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, Schuchat A (2003) Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 9:970\u2013977","journal-title":"Emerg Infect Dis"},{"key":"1385_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","volume":"335","author":"HD Davies","year":"1996","unstructured":"Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547\u2013554","journal-title":"N Engl J Med"},{"key":"1385_CR4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","volume":"45","author":"RE O\u2019Loughlin","year":"2007","unstructured":"O\u2019Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, Active Bacterial Core Surveillance Team (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004. Clin Infect Dis 45:853\u2013862","journal-title":"Clin Infect Dis"},{"key":"1385_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1086\/341409","volume":"35","author":"KL O\u2019Brien","year":"2002","unstructured":"O\u2019Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group A Streptococcus disease in the United States, 1995\u20131999. Clin Infect Dis 35:268\u2013276","journal-title":"Clin Infect Dis"},{"key":"1385_CR6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1086\/379013","volume":"37","author":"BK Eriksson","year":"2003","unstructured":"Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH (2003) Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis 37:1189\u20131193","journal-title":"Clin Infect Dis"},{"key":"1385_CR7","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/JCM.43.7.3101-3109.2005","volume":"43","author":"K Ekelund","year":"2005","unstructured":"Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinh\u00f8j P, Konradsen HB (2005) Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 43:3101\u20133109","journal-title":"J Clin Microbiol"},{"key":"1385_CR8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","volume":"45","author":"J Darenberg","year":"2007","unstructured":"Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schal\u00e9n C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45:450\u2013458","journal-title":"Clin Infect Dis"},{"key":"1385_CR9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/CDLI.12.7.833-836.2005","volume":"12","author":"JB Dale","year":"2005","unstructured":"Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (2005) Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol 12:833\u2013836","journal-title":"Clin Diagn Lab Immunol"},{"key":"1385_CR10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","volume":"41","author":"SA McNeil","year":"2005","unstructured":"McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB (2005) Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41:1114\u20131122","journal-title":"Clin Infect Dis"},{"key":"1385_CR11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","volume":"47","author":"B Luca-Harari","year":"2009","unstructured":"Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schal\u00e9n C, Henriques-Normark B, Jasir A, Strep-EURO Study Group (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47:1155\u20131165","journal-title":"J Clin Microbiol"},{"key":"1385_CR12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0950268807007984","volume":"135","author":"T Ikebe","year":"2007","unstructured":"Ikebe T, Hirasawa K, Suzuki R, Ohya H, Isobe J, Tanaka D, Katsukawa C, Kawahara R, Tomita M, Ogata K, Endoh M, Okuno R, Tada Y, Okabe N, Watanabe H, Working Group for Beta-haemolytic Streptococci in Japan (2007) Distribution of emm genotypes among group A Streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001\u20132005. Epidemiol Infect 135:1227\u20131229","journal-title":"Epidemiol Infect"},{"key":"1385_CR13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","volume":"9","author":"AC Steer","year":"2009","unstructured":"Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611\u2013616","journal-title":"Lancet Infect Dis"},{"key":"1385_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/0022-1317-49-10-849","volume":"49","author":"A Norrby-Teglund","year":"2000","unstructured":"Norrby-Teglund A, Kotb M (2000) Host\u2013microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 49:849\u2013852","journal-title":"J Med Microbiol"},{"key":"1385_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/653082","volume":"202","author":"M Lintges","year":"2010","unstructured":"Lintges M, van der Linden M, Hilgers RD, Arlt S, Al-Lahham A, Reinert RR, Pl\u00fccken S, Rink L (2010) Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. J Infect Dis 202:20\u201328","journal-title":"J Infect Dis"},{"key":"1385_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.8.3.411","volume":"8","author":"M Kotb","year":"1995","unstructured":"Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8:411\u2013426","journal-title":"Clin Microbiol Rev"},{"key":"1385_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1469-0691.2008.02672.x","volume":"15","author":"S Rantala","year":"2009","unstructured":"Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrj\u00e4nen J (2009) Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 15:286\u2013288","journal-title":"Clin Microbiol Infect"},{"key":"1385_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2009.01.015","volume":"58","author":"S Rantala","year":"2009","unstructured":"Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrj\u00e4nen J (2009) Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect 58:266\u2013272","journal-title":"J Infect"},{"key":"1385_CR19","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1086\/379230","volume":"188","author":"FJ Schmitz","year":"2003","unstructured":"Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D, Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188:1578\u20131586","journal-title":"J Infect Dis"},{"key":"1385_CR20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10096-010-0989-9","volume":"29","author":"T Siljander","year":"2010","unstructured":"Siljander T, Lyytik\u00e4inen O, V\u00e4h\u00e4kuopus S, Snellman M, Jalava J, Vuopio J (2010) Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol 29:1229\u20131235","journal-title":"Eur J Clin Microbiol"},{"key":"1385_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/JCM.01663-08","volume":"47","author":"T Siljander","year":"2009","unstructured":"Siljander T, Lyytik\u00e4inen O, V\u00e4h\u00e4kuopus S, S\u00e4il\u00e4 P, Jalava J, Vuopio-Varkila J (2009) Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 47:477\u2013480","journal-title":"J Clin Microbiol"},{"key":"1385_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/JCM.01626-07","volume":"46","author":"B Luca-Harari","year":"2008","unstructured":"Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46:79\u201386","journal-title":"J Clin Microbiol"},{"key":"1385_CR23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1469-0691.2008.02076.x","volume":"14","author":"TL Lamagni","year":"2008","unstructured":"Lamagni TL, Neal S, Keshishian C, Hope V, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A (2008) Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003\u20132004. Clin Microbiol Infect 14:1002\u20131009","journal-title":"Clin Microbiol Infect"},{"key":"1385_CR24","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","volume":"46","author":"TL Lamagni","year":"2008","unstructured":"Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schal\u00e9n C, Jasir A, Strep-EURO Study Group (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359\u20132367","journal-title":"J Clin Microbiol"},{"key":"1385_CR25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3201\/eid1107.040900","volume":"11","author":"SH Factor","year":"2005","unstructured":"Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, Wright C, Schwartz B, Schuchat A (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11:1062\u20131066","journal-title":"Emerg Infect Dis"},{"key":"1385_CR26","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2008.06.073","volume":"26","author":"C Spindler","year":"2008","unstructured":"Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A (2008) Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine 26:5541\u20135546","journal-title":"Vaccine"},{"key":"1385_CR27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1469-0691.2008.02031.x","volume":"14","author":"SI Aguiar","year":"2008","unstructured":"Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens (2008) Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect 14:835\u2013843","journal-title":"Clin Microbiol Infect"},{"key":"1385_CR28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","volume":"13","author":"MW Cunningham","year":"2000","unstructured":"Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470\u2013511","journal-title":"Clin Microbiol Rev"},{"key":"1385_CR29","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.68.6.3523-3534.2000","volume":"68","author":"S Chatellier","year":"2000","unstructured":"Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M (2000) Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68:3523\u20133534","journal-title":"Infect Immun"},{"key":"1385_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","volume":"3","author":"AL Bisno","year":"2003","unstructured":"Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3:191\u2013200","journal-title":"Lancet Infect Dis"},{"key":"1385_CR31","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/IAI.61.8.3369-3374.1993","volume":"61","author":"DF Talkington","year":"1993","unstructured":"Talkington DF, Schwartz B, Black CM, Todd JK, Elliott J, Breiman RF, Facklam RR (1993) Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 61:3369\u20133374","journal-title":"Infect Immun"},{"key":"1385_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","volume":"321","author":"DL Stevens","year":"1989","unstructured":"Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1\u20137","journal-title":"N Engl J Med"},{"key":"1385_CR33","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1073\/pnas.88.7.2668","volume":"88","author":"JM Musser","year":"1991","unstructured":"Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 88:2668\u20132672","journal-title":"Proc Natl Acad Sci USA"},{"key":"1385_CR34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/314872","volume":"180","author":"BK Eriksson","year":"1999","unstructured":"Eriksson BK, Andersson J, Holm SE, Norgren M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180:410\u2013418","journal-title":"J Infect Dis"},{"key":"1385_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/166.1.31","volume":"166","author":"SE Holm","year":"1992","unstructured":"Holm SE, Norrby A, Bergholm AM, Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988\u20131989. J Infect Dis 166:31\u201337","journal-title":"J Infect Dis"},{"key":"1385_CR36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/clind\/16.6.792","volume":"16","author":"B Demers","year":"1993","unstructured":"Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE (1993) Severe invasive group A streptococcal infections in Ontario, Canada: 1987\u20131991. Clin Infect Dis 16:792\u2013800","journal-title":"Clin Infect Dis"},{"key":"1385_CR37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/514567","volume":"26","author":"PR Hsueh","year":"1998","unstructured":"Hsueh PR, Wu JJ, Tsai PJ, Liu JW, Chuang YC, Luh KT (1998) Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 26:584\u2013589","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1385-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1385-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T20:32:18Z","timestamp":1592857938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,30]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1385-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,30]]}}}